• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Footnote

Footnote.co

Showcasing research with the power to change our world

  • Facebook
  • Twitter
Footnote
  • About
  • Contributors
  • Partner With Us
  • Press
  • Projects
  • Academia
  • Business
  • Education
  • Government
  • Health
  • International
  • Science
  • Society
  • Technology
Scholar Spotlight

Exploring The Mechanics Of Why We Get Sick

Elizabeth Nolan, MITAugust 15, 2013May 19, 2017
Sections
  • Academia
  • Health
  • Scholar Spotlight
Topics
  • Biochemistry
  • Immunology
  • Scholar Spotlight
  • Scientific Discovery

Just three years after finishing her Ph.D. program, Liz Nolan was appointed as an Assistant Professor in the Department of Chemistry at MIT. She manages a lab of twelve researchers working to understand the competition for resources that happens inside our bodies when we get sick. Footnote spoke with Nolan about her research, collaboration across disciplines, and ‘eureka moments’.

Can you provide an explanation of your research for the non-scientists out there?

 We’re interested in the host-pathogen interaction, and in particular the role of metal ions in this interaction. So, we’re all familiar with bacterial infection and getting sick, and in order for these microbial pathogens to colonize they need essential nutrients, including metal ions.(a) All organisms have a lot of machinery to transport and store these metal ions, and so we look at that machinery from a molecular perspective, at the level of atoms and molecules. We also look more broadly at the tug-of-war between the bacterial pathogen and the host for the acquisition of these metals.

One way in which the host attempts to prevent microbial colonization is to block metal-ion acquisition by the invading pathogen. To do so, the host synthesizes and secretes various polypeptides that have the capacity to sequester metal ions and thereby limit the availability of these essential nutrients.(b) In essence, the pathogen is starved. Understanding this type of host response to infection may provide new approaches for antibiotic development.

What is the ultimate goal of your research? What successes would you like to see five or ten years down the line?

In the long-term it is certainly possible that our work will impact the development of new therapies, or new iterations on current therapies, so we’re interested in that. But our questions are also quite fundamental in terms of using the tools of chemistry to understand the biological system and providing a molecular-level depiction of a working model. We’d like to understand the fundamental molecular mechanisms of some of the host-response proteins we’re currently investigating. And that knowledge is certainly necessary to improve antibiotics and other treatments.

The idea of a ‘eureka’ moment is often applied to scientific discovery. What’s the last big eureka moment you had?

I think that eureka moments are when you have a really exciting result – even though you may or may not understand what that result actually means yet – or when you find an essential piece to a complex puzzle that provides new understanding.(c) One I experienced recently was in an area we’re trying to understand about the mechanisms of certain naturally occurring antimicrobial peptides, and through a scanning approach we have some very interesting leads. In another direction, we’re trying to do some work that will allow us to target molecules in a certain subspecies of bacteria, and we have some very exciting results there as well.

Your work blends knowledge and techniques from several scientific disciplines, and you collaborate with specialists from many fields.(d) Why do you find it important to do multidisciplinary research?

I think it’s important to find collaborators who are dedicated to similar questions and problems but have a complementary skill-set. People in my group have different backgrounds depending on their major or their personal interests or what they did as a Ph.D. student. We also seek out external collaborators with complementary backgrounds in order to get the full perspective on the system. For example, we’re interested in this host-pathogen interaction, so we’re very interested in the biology, but we’re chemists and don’t have the expertise on animal-model studies, the medical perspective, all of that. And, on the other hand, there are areas of chemistry where we need expertise, so we seek outside collaborators there.

Sometimes partnerships can even happen by accident. For one collaboration, it just happened that I was at a meeting and this collaborator-to-be was at the meeting, and we had all these overlapping interests. She’s a physician and a microbiologist and I’m a chemist, so that was serendipitous and just terrific.

Is there a bit of research over the past six months or year that you think should be on the mainstream radar but isn’t?

It’s hard to assess what the general public actually knows and doesn’t know when it comes to the latest scientific research. Related to my field, broadly, I think that making the public more aware of the roles of metals in biology, which affect human health and disease, is important. It’s about more than just taking your iron supplement.

When was the last time you read about a new piece of research that made you think, “Wow, that’s really important”?

Probably last night. Haha, that long ago! A study in Science about aspects of outer-membrane stress response in e coli.

Related

  1. robotics
    Microbots, Robot Swarms, And Other News From The Future
  2. intuition
    Combating Bad Intuitions With Good Science
  3. red or blue?
    How Should We Weigh Conflicting Advice About Our Health?

Sidenotes

  • (a) Over 30% of proteins require metal ions to function properly.
  • (b) The metal ions manganese, iron, and zinc are of particular importance during infection.
  • (c) The word eureka comes from the Greek heúrēka, which means “I found it.” Its use is attributed to the ancient Greek thinker Archimedes.
  • (d) Dr. Nolan’s research draws on approaches from inorganic and organic chemistry, biochemistry, enzymology, and cell biology.

sidebar

Contributed by

Elizabeth Nolan

Elizabeth Nolan

Assistant Professor, Department of Chemistry
MIT

Liz Nolan was raised in Niskayuna, New York and graduated magna cum laude from Smith College in 2000 with highest honors in chemistry and a minor in music. Liz conducted her graduate studies in inorganic chemistry at the Massachusetts Institute of Technology, where she joined the laboratory of Professor Stephen J. Lippard. Her doctoral work focused on the synthesis, characterization, and application of small-molecule fluorescent sensors for detecting zinc in biological samples and mercury in aqueous solution. Liz pursued post-doctoral research in the laboratory of Professor Christopher T. Walsh at Harvard Medical School where she investigated the biosynthetic assembly of microcin E492m, an antibiotic “Trojan horse” peptide that targets Gram-negative bacteria expressing siderophore uptake pumps. Liz joined the Department of Chemistry at MIT as an assistant professor in 2009. Her current research interests include synergies between metal ion homeostasis and immunity, and the roles of host-defense peptides and metalloproteins in various biological phenomena. Liz received a 2010 NIH New Innovator Award, and she was named a Searle Scholar in 2011 and an Alfred P. Sloan Foundation Fellow in 2013.

Footer

About Footnote

Footnote is an online media company that increases the impact of academic knowledge by making it accessible and engaging for new audiences.

Learn more about Footnote and our contributors.

Follow us on Facebook and Twitter.

Partner with us to increase the impact of your research.

Sections

  • Academia
  • Business
  • Education
  • Government
  • Health
  • International
  • Science
  • Society
  • Technology

Projects

  • Babson College
  • The Collaborative
  • Genomic Medicine
  • Making Research Reliable
  • Robotics
  • Works Cited Podcast

© 2025 Footnote